About CLINUVEL

RH

Corporate Governance

The CLINUVEL Board is committed to good corporate governance. CLINUVEL's corporate governance policies are available for review and download via the links below.

 Date  Title Download
 February 2017  Corporate Governance Protocol Download
 February 2017  Board Charter Download
 November 2017  Remuneration Committee Charter Download
 November 2017  Audit & Risk Committee Charter Download
 July 2017  Diversity Policy Download
 February 2017  Nomination Committee Charter Download

2017 Corporate Governance Statement

CLINUVEL's 2017 Corporate Governance Statement can be downloaded here.

Latest Company Announcements

26 March 2018

CLINUVEL Newsletter - March 2018

The erythropoietic protoporphyria (EPP) Expert Meeting in Vienna on 16 March has had quite an impact on our global teams working in the fields of photomedicine and melanocortins.

Read More
19 March 2018

CLINUVEL HOLDS EUROPEAN ERYTHROPOIETIC PROTOPORPHYRIA (EPP) EXPERT MEETING

CLINUVEL PHARMACEUTICALS LTD today announced the results of the third European meeting on erythropoietic protoporphyria (EPP) held in Vienna, Austria, on Friday 16 March.

Read More
21 February 2018

CLINUVEL sustains profitability first-half of year

CLINUVEL PHARMACEUTICALS LTD today announced financial results for the half year ended 31 December 2017, reporting net profit after tax of A$1.41m, and total revenues of A$7.19m.

Read More
13 February 2018

CLINUVEL unveils new global positioning

CLINUVEL PHARMACEUTICALS LTD today released its new global Company positioning including the unveiling of a new Group identity and website.

Read More
12 February 2018

CLINUVEL Newsletter - February 2018

We started this year with limitless optimism and energy, and I attribute this to a foundation of internal changes made over the past 16 months

Read More
31 January 2018

Appendix 3X - Karen Agersborg

Appendix 3X - Karen Agersborg

Read More

Quick Links